Medidata Collaborates with Leading New York Cancer Center to Expand the Use of mHealth Technology in Oncology Care

Go back to Medidata Collaborates with Leading New York Cancer Center to Expand the Use of mHealth Technology in Oncology Care

Needham & Company Reiterates Buy on Medidata Solutions (MDSO) Following Strong 2Q Results

July 21, 2016 8:32 AM EDT

Needham & Company reiterated a Buy rating on Medidata Solutions (NASDAQ: MDSO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. MDSO reported revenues of $114.6mm, ahead of $112.4mm estimate. EPS of $0.24 also beat estimates with a $0.23 consensus.

Analyst Scott Berg... More